{"codeSystem":{"caseSensitive":false,"concept":[{"code":"I","display":"Schedule I","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-comments","valueString":"Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision."}]},{"code":"II","display":"Schedule II","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-comments","valueString":"Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability."}]},{"code":"III","display":"Schedule III","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-comments","valueString":"Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States."}]},{"code":"IV","display":"Schedule IV","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-comments","valueString":"Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States."}]},{"code":"V","display":"Schedule V","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-comments","valueString":"Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States."}]},{"code":"VI","display":"Schedule VI","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-comments","valueString":"State defined"}]}],"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-oid","valueUri":"urn:oid:2.16.840.1.133883.18.304"}],"system":"http://hl7.org/fhir/v2/0477"},"contact":[{"telecom":[{"system":"other","value":"http://hl7.org"}]}],"description":"FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)","experimental":true,"id":"v2-0477","meta":{"profile":["http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"]},"name":"v2 Controlled Substance Schedule","publisher":"HL7, Inc","resourceType":"ValueSet","status":"active","text":{"div":"<div><p>Controlled Substance Schedule</p>\r\n<table class=\"grid\"><tr><td><b>Code</b></td><td><b>Description</b></td><td><b>Comment</b></td><td><b>Version</b></td></tr><tr><td>I<a name=\"I\"> </a></td><td>Schedule I</td><td>Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.</td><td>added v2.5</td></tr><tr><td>II<a name=\"II\"> </a></td><td>Schedule II</td><td>Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.</td><td>added v2.5</td></tr><tr><td>III<a name=\"III\"> </a></td><td>Schedule III</td><td>Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.</td><td>added v2.5</td></tr><tr><td>IV<a name=\"IV\"> </a></td><td>Schedule IV</td><td>Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.</td><td>added v2.5</td></tr><tr><td>V<a name=\"V\"> </a></td><td>Schedule V</td><td>Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.</td><td>added v2.5</td></tr><tr><td>VI<a name=\"VI\"> </a></td><td>Schedule VI</td><td>State defined</td><td>added v2.5</td></tr></table>\r\n</div>","status":"additional"},"url":"http://hl7.org/fhir/ValueSet/v2-0477","version":"2.8.2"}